C B PHARMA ACQUISITION CORP's ticker is CNLM and the CUSIP is G2029P126. A total of 8 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,535,000 | – | 350,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weiss Asset Management LP | 423,246 | $4,211,000 | 1.07% |
| Polar Asset Management Partners Inc. | 550,000 | $5,472,000 | 0.28% |
| Karpus Management, Inc. | 131,601 | $1,309,000 | 0.06% |
| AQR Arbitrage LLC | 350,000 | $3,483,000 | 0.04% |
| GLAZER CAPITAL, LLC | 21,824 | $224,000 | 0.03% |
| Yakira Capital Management, Inc. | 12,500 | $124,000 | 0.03% |
| MORGAN STANLEY | 10 | $0 | 0.00% |
| UBS Group AG | 1,233 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 203 | $2,000 | 0.00% |